Schedule 13G ownership disclosure

Puma Biotechnology Inc

Security class unavailable · CUSIP: 74587V107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,905,523
Percent of class
10.0400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-061478
Form type
SC 13G/A
Filer
PUMA BIOTECHNOLOGY, INC.
CIK
CIK 1401667
Filed
Nov 08, 2019
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub